Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018086530) SULFONAMIDE COMPOUND AS CCCDNA INHIBITOR
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/086530 International Application No.: PCT/CN2017/109922
Publication Date: 17.05.2018 International Filing Date: 08.11.2017
IPC:
C07D 231/24 (2006.01) ,C07D 207/27 (2006.01) ,C07D 309/14 (2006.01) ,A61P 1/16 (2006.01) ,A61P 31/20 (2006.01) ,A61K 31/18 (2006.01)
[IPC code unknown for C07D 231/24][IPC code unknown for C07D 207/27][IPC code unknown for C07D 309/14][IPC code unknown for A61P 1/16][IPC code unknown for A61P 31/20][IPC code unknown for A61K 31/18]
Applicants:
正大天晴药业集团股份有限公司 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. [CN/CN]; 中国江苏省连云港市 郁州南路369号 No. 369 Yuzhou South Rd. Lianyungang, Jiangsu 222062, CN
南京明德新药研发股份有限公司 MEDSHINE DISCOVERY INC. [CN/CN]; 中国江苏省南京市 高新开发区高新路9号商务办公楼218室 Room 218, No.9 Gaoxin Road Gaoxin Development District Nanjing, Jiangsu 210032, CN
Inventors:
付志飞 FU, Zhifei; CN
张杨 ZHANG, Yang; CN
罗妙荣 LUO, Miaorong; CN
陈曙辉 CHEN, Shuhui; CN
黎健 LI, Jian; CN
徐宏江 XU, Hongjiang; CN
杨玲 YANG, Ling; CN
张喜全 ZHANG, Xiquan; CN
Agent:
北京英赛嘉华知识产权代理有限责任公司 INSIGHT INTELLECTUAL PROPERTY LIMITED; 中国北京市 海淀区知春路甲48号盈都大厦A座19A 19 A, Tower A, InDo Building No. 48A Zhichun Road, Haidian District Beijing 100098, CN
Priority Data:
201610980092.308.11.2016CN
Title (EN) SULFONAMIDE COMPOUND AS CCCDNA INHIBITOR
(FR) COMPOSÉ DE SULFONAMIDE EN TANT QU'INHIBITEUR DE L'ADNCCC
(ZH) 作为cccDNA抑制剂的磺酰胺类化合物
Abstract:
(EN) Provided is a series of sulfonamide compounds as a cccDNA inhibitor. Particularly, the present invention relates to a compound represented by formula (I) as a cccDNA inhibitor or a pharmaceutically acceptable salt thereof.
(FR) L'invention concerne une série de composés de sulfonamide en tant qu'inhibiteur de l'ADNccc. En particulier, la présente invention concerne un composé représenté par la formule (I) en tant qu'inhibiteur de l'ADNccc ou un sel pharmaceutiquement acceptable de celui-ci.
(ZH) 提供一系列作为cccDNA 抑制剂的磺酰胺类化合物,具体地,涉及作为cccDNA抑制剂的式(Ⅰ)所示化合物或药学上可接受的盐
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)